Lubelski Daniel, Healy Andrew T, Silverstein Michael P, Alvin Matthew D, Abdullah Kalil G, Benzel Edward C, Mroz Thomas E
Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, 9500 Euclid Ave., Cleveland Ohio 44195, USA; Center for Spine Health, Cleveland Clinic, 9500 Euclid Ave., S-40, Cleveland, OH 44195, USA; Department of Neurological Surgery, Cleveland Clinic, 9500 Euclid Ave., Cleveland Ohio 44195, USA.
Center for Spine Health, Cleveland Clinic, 9500 Euclid Ave., S-40, Cleveland, OH 44195, USA; Department of Neurological Surgery, Cleveland Clinic, 9500 Euclid Ave., Cleveland Ohio 44195, USA.
Spine J. 2015 Jan 1;15(1):18-24. doi: 10.1016/j.spinee.2014.06.013. Epub 2014 Jun 18.
Differentiating between multiple sclerosis (MS) and cervical stenosis (CS) can be difficult because of their overlapping symptoms. Although studies have shown preoperative imaging criteria that are predictive of outcomes in either MS or CS individually, no studies have investigated these factors in patients that have concurrent MS and CS.
To investigate the associations between preoperative magnetic resonance imaging (MRI) findings and postoperative outcomes in patients with concurrent MS and CS with myelopathy.
A retrospective review.
All patients presenting with myelopathy who underwent cervical decompression surgery at a single tertiary-care institution between January 1996 and July 2011, diagnosed with concurrent MS and CS.
Pre- and postoperative severity of myelopathy was assessed using the modified Japanese Orthopaedic Association (mJOA) scale.
Preoperative imaging was assessed for stenosis, lesions, signal intensity (graded low, intermediate, or high), extent of lesion (focal or diffuse), and cord atrophy. Imaging was then correlated with postoperative myelopathy outcomes.
Forty-eight patients with MS and CS were reviewed for an average follow-up of 53 months. In the short term after surgery, there were 24 patients (50%) who showed improvement in the mJOA myelopathy score and 24 (50%) who did not improve. Significantly greater percentage of patients in the improvement group had high-intensity lesions on preoperative MRI as compared with the no-improvement group (p=.03). At long-term follow-up, there were 18 patients (37.5%) who showed postoperative improvement and 30 patients (62.5%) with no improvement. No significant differences were identified on preoperative imaging between those who improved postoperatively and those who did not.
Although certain characteristic preoperative MRI findings are associated with postoperative outcomes in cohorts of either MS or CS patients, we did not find this to be the case in patients with concurrent MS and CS. Accordingly, the treatment of the MS/CS patient population should be unique as their outcomes may not be as good as those with CS but no MS.
由于多发性硬化症(MS)和颈椎管狭窄症(CS)症状重叠,鉴别二者可能存在困难。尽管研究已表明术前影像学标准可分别预测MS或CS患者的预后,但尚无研究对同时患有MS和CS的患者中的这些因素进行调查。
研究同时患有MS和CS并伴有脊髓病的患者术前磁共振成像(MRI)表现与术后预后之间的关联。
一项回顾性研究。
1996年1月至2011年7月期间在一家三级医疗机构接受颈椎减压手术、被诊断为同时患有MS和CS且伴有脊髓病的所有患者。
采用改良日本骨科协会(mJOA)量表评估术前和术后脊髓病的严重程度。
对术前影像学检查评估狭窄、病变、信号强度(分为低、中或高等级)、病变范围(局灶性或弥漫性)以及脊髓萎缩情况。然后将影像学表现与术后脊髓病预后进行关联分析。
对48例同时患有MS和CS的患者进行了回顾性研究,平均随访53个月。术后短期内,24例患者(50%)的mJOA脊髓病评分有所改善,24例患者(50%)未改善。与未改善组相比,改善组患者术前MRI上高强度病变的比例显著更高(p = 0.03)。长期随访时,18例患者(37.5%)术后有所改善,30例患者(62.5%)未改善。术后改善患者与未改善患者术前影像学检查未发现显著差异。
尽管某些特定的术前MRI表现与MS或CS患者队列的术后预后相关,但我们发现同时患有MS和CS的患者并非如此。因此,MS/CS患者群体的治疗应具有独特性,因为他们的预后可能不如仅患有CS而无MS的患者。